These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11122575)

  • 21. GSK is fined £38m for delaying generic paroxetine.
    Dyer C
    BMJ; 2016 Feb; 352():i917. PubMed ID: 26873503
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical practice guidelines for depression in young people.
    Jureidini JN; Tonkin AL
    Med J Aust; 2003 Mar; 178(6):300; author reply 300-2. PubMed ID: 12633493
    [No Abstract]   [Full Text] [Related]  

  • 23. An open trial of paroxetine in the treatment of children and adolescents diagnosed with dysthymia.
    Nobile M; Bellotti B; Marino C; Molteni M; Battaglia M
    J Child Adolesc Psychopharmacol; 2000; 10(2):103-9. PubMed ID: 10933120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Increased perioperative blood loss during treatment with paroxetine].
    Sewnath ME; van Hillegersberg R; Koopman MM; Levi MM; Gouma DJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(38):1800-2. PubMed ID: 12369443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of Paroxetine for Poststroke Depression: A Meta-Analysis.
    Li L; Han Z; Li L; Han L; Yan B
    J Stroke Cerebrovasc Dis; 2020 May; 29(5):104664. PubMed ID: 32093988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline.
    Pezzella G; Moslinger-Gehmayr R; Contu A
    Breast Cancer Res Treat; 2001 Nov; 70(1):1-10. PubMed ID: 11766999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.
    Weihs KL; Settle EC; Batey SR; Houser TL; Donahue RM; Ascher JA
    J Clin Psychiatry; 2000 Mar; 61(3):196-202. PubMed ID: 10817105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips.
    Jha MK; Rush AJ; Trivedi MH
    Am J Psychiatry; 2018 Dec; 175(12):1176-1184. PubMed ID: 30501420
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up].
    Horváth S; Karányi Z; Harcos P; Nagy Z; Németh G; Andor G
    Orv Hetil; 2006 Dec; 147(50):2397-404. PubMed ID: 17274185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Potentialities of treating secondary dysthymia with painful dysfunction of temporomandibular joint].
    Gorozhankina EA; Markov BP; Mamedov FM
    Stomatologiia (Mosk); 2003; 82(5):44-7. PubMed ID: 14608350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correction of affective disorders in patients with alcohol dependence].
    Litvintsev SV; Reznik AM; Arbuzov AL; Kutushev OT; Martyniuk IuL; Khurbatova IG
    Voen Med Zh; 2002 Jul; 323(7):42-5. PubMed ID: 12192987
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults.
    Williams JW; Barrett J; Oxman T; Frank E; Katon W; Sullivan M; Cornell J; Sengupta A
    JAMA; 2000 Sep; 284(12):1519-26. PubMed ID: 11000645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paroxetine treatment of trichotillomania in an adolescent.
    Block C; West SA; Baharoglu B
    J Child Adolesc Psychopharmacol; 1998; 8(1):69-71. PubMed ID: 9639081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and tolerability of venlafaxine in the treatment of primary dysthymia.
    Ravindran AV; Charbonneau Y; Zaharia MD; al-Zaid K; Wiens A; Anisman H
    J Psychiatry Neurosci; 1998 Nov; 23(5):288-92. PubMed ID: 9846033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.
    Morishita S; Arita S
    Eur Psychiatry; 2003 Dec; 18(8):418-20. PubMed ID: 14680720
    [No Abstract]   [Full Text] [Related]  

  • 36. Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control study.
    Van Holten TC; Roest M; Riphagen J; Jansen C; Naarding P; Adriaansen HJ; De Groot PG; Remijn JA
    J Thromb Haemost; 2012 Jun; 10(6):1177-9. PubMed ID: 22429872
    [No Abstract]   [Full Text] [Related]  

  • 37. Nonadherence to paroxetine: a study based on monitoring plasma paroxetine levels.
    Yoshimura R; Ikenouchi-Sugita A; Umene-Nakano W; Hori H; Ueda N; Nakamura J
    J Clin Psychopharmacol; 2010 Feb; 30(1):82-3. PubMed ID: 20075657
    [No Abstract]   [Full Text] [Related]  

  • 38. The paroxetine controversy: lessons for ketamine trials.
    Zhang MW; Ho RC
    Lancet Psychiatry; 2015 Dec; 2(12):1057-8. PubMed ID: 26613847
    [No Abstract]   [Full Text] [Related]  

  • 39. Serotonin syndrome in a prisoner.
    Zimmerschied JA; Harry B
    J Forensic Sci; 1998 Jan; 43(1):208-9. PubMed ID: 9456547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative efficacy and tolerability of paroxetine and amitriptiline in long-term therapy preventing depressive recurrences].
    Mosolov SN; Kostiukova EG; Gorodnichev AV; Timofeev IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(10):22-9. PubMed ID: 16281375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.